Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet

Summary

To Evaluate the Efficacy and Safety of CKD-495

Timeline

Start

2018-01-16

Primary completion

2018-10-12

Completion

2018-10-12

Outcome

Met primary endpoint

paper The endoscopic erosion improvement rate was significantly higher in the 75 mg CKD-495 group than in the other groups PMID 40255536 ↗

Publications

• Park SH, Lee OY, Lee YC, Park KS, Park JJ, Park MI, Song GA, Lee DH, Jung H, Kim SK, Kim TN, Choi SC, Jee SR, Rew JS, Lee ST, Choi EK, Baik GH, Park SJ. A Phase 2, Multi-Center, Randomized, Double-Blind, Parallel-Group Trial to Evaluate the Efficacy and Safety of CKD-495 in Patients With Acute and Chronic Gastritis. Can J Gastroenterol Hepatol. 2025 Apr 10;2025:2702089. doi: 10.1155/cjgh/2702089. eCollection 2025.

Drugs

Indications